Hyderabad, Nov 15 (Hydnow): Hyderabad now boasts of four billionaires who have secured positions in the prestigious ‘India’s 100 Richest‘ list for 2023.
In the recent list by Forbes, Hyderabad billionaires in the Forbes roster are Murali Divi and family, securing the 33rd spot with a staggering net worth of $6.3 billion. Murali Divi, a US-trained scientist founded generic drugs make Divi’s Laboratories 33 years ago, initially establishing it as a drug research firm.
Today, the company stands tall among the world’s leading suppliers of active pharmaceutical ingredients. Forbes highlighted that Divi’s Laboratories not only engages in custom manufacturing for prominent pharmaceutical firms but also produces nutraceuticals.
Following closely P.P. Reddy & P.V. Krishna Reddy clinched the 54th position with a net worth of $4.05 billion. P.P Reddy, hailing from an agricultural background, founded Megha Engineering Enterprises in 1989, primarily focusing on constructing small pipes for municipalities. However, the company swiftly expanded its portfolio to encompass monumental infrastructure projects, including dams, natural gas distribution networks, power plants, and roads.
Renamed Megha Engineering & Infrastructures in 2006, the company, the company, led by P.V Krishna Reddy since 1991, achieved a milestone by completing India’s largest lift irrigation project, valued at a substantial $14 billion, in Telangana, Forbes noted that the subsidiary Olectra Greentech, leveraging technology from China’s BYD, boasts an impressive order book, crossing 3,000 buses.
Dr. Reddy’s family secured the 75th position, amassing a net worth of $3 billion, largely attributed to their stake in the renowned generics maker. Dr. Reddy’s Laboratories, Founded in 1984 by the late K.Anji Reddy, the company focused on producing pharmaceutical ingredients and generics. The firm garners over a third of its revenue from North America and more than a fourth from India, as per Forbes.
P.V. Ramprasad Reddy claimed the 98th spot on the Forbes list, boasting a net worth of $2.35 billion. Serving on the board of Aurobindo Pharma, which he co-founded in 1986. P.V. Ramprasad Reddy contributes to the production of drugs addressing various ailments like diabetes and cardiac issues.
With a significant portion of its revenue sourced from the U.S. and Europe, Aurobindo Pharma received approval in September 2023 to launch the cancer drug Revlimid in India. (Hydnow)
Next Story :
-
Heavy Rains In Telangana For Next Three Days
The people of Telangana have been alerted because of moderate to heavy rains in the state for the next three days, according to the Indian Meteorological Department (IMD).
Now you can get the latest stories from Hydnow every day. Click the link to subscribe. Click to follow Hydnow’s Facebook page and Twitter and Instagram